Press release
United States Diabetes Management Apps Market 2025-2033: AI-Driven Mobile Solutions, Personalized Healthcare, and Real-Time Glucose Monitoring Transforming Diabetes Care | Recent Product Launches 2025
Diabetes Management Apps Market
The Diabetes Management Apps Market encompasses mobile applications designed to assist individuals in monitoring and managing their diabetes effectively. These apps offer features such as blood glucose tracking, medication reminders, dietary logs, and integration with wearable devices, facilitating real-time health monitoring. The market is experiencing significant growth, driven by the increasing prevalence of diabetes, rising smartphone penetration, and the demand for personalized healthcare solutions.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Diabetes Management Apps Market Landscape:- https://datamintelligence.com/download-sample/diabetes-management-apps-market?rk
☛ Diabetes Management Apps Market Recent Developments 2025:
United States: Recent Industry Developments
✅ In August 2025, Dexcom launched a new mobile app integrating real-time continuous glucose monitoring (CGM) data with AI-driven insights to improve glycemic control for diabetic patients.
✅ In July 2025, Livongo (Teladoc Health) expanded its diabetes management platform with telehealth integration and personalized coaching, targeting both Type 1 and Type 2 diabetes patients.
✅ In June 2025, Glooko partnered with U.S. hospitals to provide cloud-based diabetes apps, enabling seamless data sharing between patients and healthcare providers for better treatment adherence.
Europe: Recent Industry Developments
✅ In July 2025, mySugr (Roche) introduced enhanced European versions of its diabetes management app, incorporating AI-based carb tracking and predictive alerts for insulin dosing.
✅ In June 2025, Diasend (CompuGroup Medical) expanded app adoption across EU countries, integrating CGM, insulin pumps, and lifestyle tracking in one unified platform.
✅ In May 2025, Medtronic Europe launched AI-powered analytics in its diabetes apps, helping patients and clinicians monitor trends and prevent complications in Type 1 and Type 2 diabetes.
Japan: Recent Industry Developments
✅ In July 2025, Omron Healthcare Japan launched a mobile diabetes app linked with wearable glucometers, enabling real-time monitoring and lifestyle recommendations.
✅ In June 2025, Terumo Corporation integrated AI-driven predictive alerts into its diabetes management platform to support early intervention in Japanese patients.
✅ In May 2025, Fujitsu collaborated with Japanese hospitals to deploy personalized diabetes apps, combining continuous monitoring, telehealth, and AI insights for improved disease management.
☛ Diabetes Management Apps Recent Product Launches:
1. Roche's AI-Powered Diabetes Management App
In June 2025, Roche launched an AI-powered app designed to enhance diabetes management. The app integrates with Roche's continuous glucose monitoring (CGM) sensor to provide real-time glucose forecasts, detect potential hypoglycemic events up to 30 minutes in advance, and offer nighttime alerts to reduce the risk of nocturnal lows. By leveraging machine learning algorithms, the app empowers users with predictive insights for better diabetes control.
2. Gluroo - Collaborative Diabetes Management
Gluroo, a collaborative diabetes management app, facilitates real-time data sharing among users and their caregivers. Its features include food logging with photos, barcode supply tracking, smartwatch integration, and chat-based logging and reminders. Gluroo is particularly beneficial for families and caregivers aiming to stay synchronized in managing diabetes care.
3. Dexcom G7 App Enhancements
Dexcom's G7 app, released in 2025, introduced new features to improve user experience. These include a 7-day Glucose Management Indicator (GMI), customizable target ranges, and enhanced event logging capabilities. The app also offers smart food logging and visual event insights, providing users with comprehensive data to manage their diabetes effectively.
4. Universal Libre App
Abbott's new Universal Libre app, launched in April 2025, consolidates the functionalities of previous Libre 2 and Libre 3 apps into a single platform. This update simplifies the user experience by eliminating the need for multiple app downloads and allows seamless compatibility with various Libre sensors, including Libre 2, Libre 3, Libre 2+, and Libre 3+.
5. Tandem t:slim Mobile App
Tandem Diabetes Care announced the release of its t:slim mobile app, authorized by Health Canada in September 2025. The app is available for compatible smartphones and aims to enhance user experience by providing remote control and monitoring capabilities for Tandem's t:slim insulin pumps.
☛ Diabetes Management Apps Market Competitve Landscape:
Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, SquareMed Software GmbH, Health2Sync, iHealth Labs Inc., and SIRMA MEDICAL SYSTEMS AD, among others
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/diabetes-management-apps-market
☛ Segment Covered in the Diabetes Management Apps Market:
By Subscription Model: Free Subscription Model, Paid Subscription Model.
By Type of Service: Digital Diabetes Management, Diabetic Weight & Diet Management.
By Operating System (OS) Platform: Android, iOS.
By Application: Home-Based Diabetes Management, AI-Based Predictive Diabetes Analytics.
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Diabetes Management Apps Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=diabetes-management-apps-market
☛ Regional Analysis for Diabetes Management Apps Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
☛ Frequently asked questions:
âž What is the global sales, production, consumption, import, and export value of the Diabetes Management Apps Market?
âž Who are the key global manufacturers, and what is their operational performance?
âž What are the major opportunities and threats in the global Diabetes Management Apps Market?
âž Which product types or end-users show the most growth potential and market share?
âž What challenges and constraints are impacting the Diabetes Management Apps Market?
âž What sales, marketing, and distribution channels are used globally?
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Diabetes Management Apps Market 2025-2033: AI-Driven Mobile Solutions, Personalized Healthcare, and Real-Time Glucose Monitoring Transforming Diabetes Care | Recent Product Launches 2025 here
News-ID: 4201895 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Global Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors Market 202 …
Global Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors Market reached US$ 14.12 billion in 2024 and is expected to reach US$ 22.34 billion by 2033, growing at a CAGR of 5.9 % during the forecast period of 2025-2033.
Vascular Endothelial Growth Factor Receptor (VEGFR) inhibitors are drugs that block VEGFR signaling pathways, which regulate angiogenesis-the formation of new blood vessels. They are primarily used in oncology to restrict tumor growth by…
United States Electric Vehicle Market Forecast 2025-2032: Impact of Next-Generat …
Global Electric Vehicle Market reached US$599.50 billion in 2024 and is expected to reach US$1,194.54 billion by 2032, growing with a CAGR of 9% during the forecast period 2025-2032.
The global electric vehicle market encompasses battery-electric, plug-in hybrid, and fuel cell vehicles. EVs are adopted to reduce carbon emissions, improve fuel efficiency, and meet regulatory mandates. Growth is fueled by technological advances in batteries, charging infrastructure, and government incentives. Consumer preference…
Global Lymphedema Market 2025-2033: Advancements in Compression Therapy, Minimal …
The Global Lymphedema Market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033, growing at a CAGR of 8.8 % during the forecast period of 2025-2033.
The global lymphedema market focuses on therapies and devices to manage this chronic condition caused by lymphatic fluid accumulation. Treatments include compression garments, physical therapy, and surgical interventions. Market growth is driven by rising prevalence, especially post-cancer surgeries.…
Lab-Grown Diamonds Market Size, Share, Growth Analysis, and Forecast (2025-2032) …
As per DataM Intelligence Experts Research Report Global lab-grown diamonds market reached US$ 25.68 billion in 2024 and is expected to reach US$ 55.45 billion by 2032, growing with a CAGR of 10.10% during the forecast period 2025-2032.
The lab-grown diamonds market involves diamonds produced using chemical vapor deposition (CVD) or high-pressure high-temperature (HPHT) methods. These diamonds are visually and chemically similar to mined diamonds but are more sustainable. Market growth…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
